This study not only highlights an anti-tumor role of immune cell derived exosomal miRNAs, but also demonstrates a novel effector mechanism by which CD8 T cells control tumor progression, independent from their canonical direct cytotoxicity against cancerous cells. The gene discussed is CD8A; the disease is neoplasm.